Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,908 | -21,548 | -12,258 | -3,177 | 0 |
| Depreciation Amortization | N/A | N/A | 174 | 123 | 0 |
| Other Working Capital | -2,251 | 1,795 | 2,077 | 1,082 | 0 |
| Other Operating Activity | 1,900 | 1,537 | 3,205 | 340 | 0 |
| Operating Cash Flow | $-26,259 | $-18,216 | $-6,802 | $-1,632 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 10,000 | -10,000 | N/A | N/A |
| Investing Cash Flow | $0 | $10,000 | $-10,000 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 637 | 1,673 | N/A |
| Debt Issued | N/A | N/A | N/A | 200 | N/A |
| Debt Repayment | N/A | N/A | -3,000 | N/A | N/A |
| Common Stock Issued | 35,000 | 0 | 37,950 | N/A | N/A |
| Other Financing Activity | -2,667 | -895 | -7,200 | -58 | 0 |
| Financing Cash Flow | $32,333 | $-895 | $28,387 | $1,815 | $0 |
| Beginning Cash Position | 2,671 | 11,782 | 197 | 14 | 0 |
| End Cash Position | 8,745 | 2,671 | 11,782 | 197 | 0 |
| Net Cash Flow | $6,074 | $-9,111 | $11,585 | $183 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,259 | -18,216 | -6,802 | -1,632 | 0 |
| Free Cash Flow | -26,259 | -18,216 | -6,802 | -1,632 | 0 |